S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Cytori and BARDA Amend Contract Option to Accelerate the Advancement of a Thermal Burn Injury Countermeasure (2014/12/19)|
|Cytori Receives Positive European Opinion on Orphan Drug Status (2015/2/24)|
|FDA Grants Cytori Conditional Approval for a U.S. Pivotal Clinical Trial in Scleroderma (2014/12/10)|
|Cytori Expects New Japan Laws to Boost Adoption of Cytori Cell Therapy (2014/12/4)|
|FDA Approves Cytori U.S. Pivotal Scleroderma Trial (2015/1/12)|
|Enrollment Begins European Knee Meniscus Injury Pilot Trial to Evaluate Cytori Cell Therapy (2015/2/10)|
|Cytori Begins Enrollment in ACT-OA: US Phase II Trial for Knee Osteoarthritis (2015/2/17)|
|Cytori and Leading Expert Discuss Importance of ‘STAR’ Trial and Treatment for Scleroderma Patients (2015/1/20)|
|FDA Approves Expansion of Pivotal Scleroderma STAR Trial to 20 Clinical Sites (2015/2/26)|
|Cytori to Host an Informational Session on Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna (2014/12/18)|
Click above to view more mutual fund data and stats for cytx - Cytori Therapeutics Inc.